Skip to content

Daewoong Co., Ltd

Reporting owner on Forms 3, 4 and 5, CIK 1985493.

Daewoong Co., Ltd reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-10.

Issuers

IssuerRoles in the latest filingFilingsLast filed
AEON · AEON Biopharma, Inc.CIK 183760710% owner12026-11-10

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value…2026-10-30X exercised+11,236,631$0.000123,188,345Form 4
AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value…2026-10-30J other-3,822$0.29423,184,523Form 4
AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value…, holding 58,023Form 4
AEON · AEON Biopharma, Inc.Pre-Funded Warrant (right to buy), derivative2026-10-30X exercised-11,236,631$00Form 4
AEON · AEON Biopharma, Inc.Common Stock Warrant (right to buy), derivative, holding 8,000,000Form 4
AEON · AEON Biopharma, Inc.Senior Secured Convertible Note, derivative, holding Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0001213900-26-117881 AEON2026-11-10
Form 4 0001213900-26-117865 AEON Biopharma, Inc.2026-11-10